For many patients in their 40s and 50s, one of the first signs of aging eyes is the frustrating loss of near vision. Known as presbyopia, this condition makes it harder to read menus in dim restaurants, check text messages, or enjoy a good book without reaching for reading glasses. While presbyopia is a natural part of aging, new treatment options are emerging that can help delay or reduce reliance on glasses.
One of the most promising new therapies is Qlosi™, an FDA-approved prescription eye drop containing pilocarpine hydrochloride 0.4%. When instilled once daily, Qlosi temporarily changes the shape of the pupil, increasing depth of focus and helping patients see clearly at near while maintaining functional distance vision. For many, it provides freedom from reading glasses for several hours each day.
Why Qlosi Is Important
Qlosi represents more than just a convenient eye drop—it marks a gateway therapy in the journey of modern vision correction. Here’s why:
- Non-invasive entry point: For patients hesitant about surgery, Qlosi allows them to experience what life could be like without constant dependence on reading glasses.
- Real-world trial run: By temporarily improving near vision, Qlosi provides a “preview” of the benefits patients might expect from more permanent surgical solutions.
- Bridging to the future: Patients who find the lifestyle benefits of Qlosi liberating often become excellent candidates for advanced surgical treatments such as Refractive Lens Exchange (RLE).
From Drops to Lens Exchange
While Qlosi provides short-term improvement, presbyopia is a progressive condition. Over time, the crystalline lens inside the eye loses flexibility and clarity, eventually leading not only to presbyopia but also to cataract formation. For long-lasting freedom from glasses, Refractive Lens Exchange with advanced multifocal or extended-depth-of-focus intraocular lenses can provide a permanent solution.
At Will Vision & Laser Centers, we routinely use premium lens implants such as:
- PanOptix Pro® trifocal IOLs – delivering sharp vision at near, intermediate, and distance
- Light Adjustable Lens (LAL®) – customizable after surgery for the most precise outcome
- Next-generation designs like the Odyssey™ IOL – promising even greater clarity and range
These technologies not only address presbyopia but also correct refractive errors like nearsightedness, farsightedness, and astigmatism—all in a single procedure.
The Bottom Line
For patients just beginning their presbyopia journey, Qlosi offers a safe and effective way to reduce dependence on reading glasses. But more importantly, it opens the door to a larger conversation: what kind of vision do you want for the rest of your life?
For many, Qlosi is the first step. For others, it is the bridge that leads to a permanent solution through refractive lens exchange with premium multifocal implants.
At Will Vision & Laser Centers, our goal is to provide personalized care and cutting-edge technology to help you achieve the clear, youthful vision you deserve—whether that begins with a simple eye drop or culminates in advanced lens surgery.
Schedule your consultation today to explore whether Qlosi—or a more permanent solution—is right for you.